Project Description
Dr. Kelly did a controlled trial with silymarin, the active ingredient of milk thistle, to determine whether it decreases liver toxicity in children receiving chemotherapy for acute lymphoblastic leukemia.
Dr. Kelly did a controlled trial with silymarin, the active ingredient of milk thistle, to determine whether it decreases liver toxicity in children receiving chemotherapy for acute lymphoblastic leukemia.